Immuto Scientific
Cambridge, Massachusetts, United States · Biotechnology, research, Therapeutics · 18 employees
Immuto is a biotechnology company that is transforming the way biotherapeutics are discovered. Protein structural analysis is an essential step in the drug discovery process, and compared to all other methods used today, our suite of proprietary technologies enables assessment of drug binding, target conformation, and interactions with an unprecedented degree of accuracy and speed. With our indust
Funding history
- Series seed — $8.0M — Sep 2025
Recent signals
- Sep 18, 2025: Raised $8.0M in Series seed
See plans & pricing → Track Immuto Scientific’s funding, hiring, and signals — with verified contacts — on Fundz.